Sodium Phenylbutyrate: Applications as a Pharmaceutical Raw Intermediate
NINGBO INNO PHARMCHEM CO.,LTD. presents Sodium Phenylbutyrate (CAS 1716-12-7), a compound recognized for its indispensable role as a pharmaceutical raw intermediate. This chemical, also known as 4-PBA, is critical for the synthesis of numerous medicinal compounds and continues to be a focus of therapeutic research due to its unique biological activities.
As a pharmaceutical raw intermediate, Sodium Phenylbutyrate is a fundamental building block in the complex process of drug manufacturing. Its consistent purity and well-defined chemical properties allow for reliable integration into synthesis pathways, ensuring the quality and efficacy of the final pharmaceutical products. Pharmaceutical companies and contract manufacturing organizations (CMOs) rely on a steady supply of high-quality sodium phenylbutyrate for their production lines. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting this demand with a product that adheres to rigorous industry standards.
The therapeutic potential of Sodium Phenylbutyrate is largely attributed to its function as a histone deacetylase (HDAC) inhibitor. This mechanism is actively explored in the development of treatments for various cancers, where HDAC inhibition can restore normal gene expression and promote cancer cell death. The compound's ability to influence cellular processes makes it a valuable subject for ongoing research in oncology and other therapeutic areas. Scientists requiring this compound for their studies are keen to buy sodium phenylbutyrate from reputable sources.
Beyond cancer treatment, 4-PBA is also under investigation for its role in managing protein misfolding diseases, such as cystic fibrosis. Its capacity to act as a chemical chaperone can help correct protein folding abnormalities, offering a potential treatment strategy for these debilitating conditions. The progression of research in these fields directly correlates with the availability of reliable sources of sodium phenylbutyrate.
NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in ensuring that the pharmaceutical industry and research institutions have consistent access to high-quality Sodium Phenylbutyrate. Our manufacturing processes are designed to maintain the integrity and purity of the compound, supporting the critical work of drug developers and researchers. For organizations seeking a dependable pharmaceutical raw intermediate, NINGBO INNO PHARMCHEM CO.,LTD. stands as a trusted partner, delivering excellence in chemical supply.
Perspectives & Insights
Agile Reader One
“is committed to meeting this demand with a product that adheres to rigorous industry standards.”
Logic Vision Labs
“The therapeutic potential of Sodium Phenylbutyrate is largely attributed to its function as a histone deacetylase (HDAC) inhibitor.”
Molecule Origin 88
“This mechanism is actively explored in the development of treatments for various cancers, where HDAC inhibition can restore normal gene expression and promote cancer cell death.”